"Chemokine CCL3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC chemokine with specificity for CCR1 RECEPTORS and CCR5 RECEPTORS. It is a chemoattractant for NK CELLS; MONOCYTES; and a variety of other immune cells. This chemokine is encoded by multiple genes.
| Descriptor ID |
D054405
|
| MeSH Number(s) |
D12.644.276.374.200.110.150 D12.644.276.374.200.600.150 D12.776.467.374.200.110.150 D12.776.467.374.200.600.150 D23.125.300.110.150 D23.125.300.600.500 D23.469.200.110.150 D23.469.200.600.150 D23.529.374.200.110.150 D23.529.374.200.600.150
|
| Concept/Terms |
Chemokine CCL3- Chemokine CCL3
- CCL3, Chemokine
- Chemokine (C-C Motif) Ligand 3
- LD78alpha Chemokine
- Chemokine, LD78alpha
- MIP-1alpha
- Small Inducible Cytokine A3
- CCL3 Chemokine
- Chemokine, CCL3
- Macrophage Inflammatory Protein 1-alpha
- Macrophage Inflammatory Protein 1 alpha
Chemokine CCL3L3- Chemokine CCL3L3
- CCL3L3, Chemokine
- CCL3L3 Chemokine
- Chemokine, CCL3L3
Chemokine CCL3L2- Chemokine CCL3L2
- CCL3L2, Chemokine
- Chemokine (C-C Motif) Ligand 3-Like 2
- CCL3L2 Chemokine
- Chemokine, CCL3L2
Chemokine CCL3L1- Chemokine CCL3L1
- CCL3L1, Chemokine
- Chemokine (C-C Motif) Ligand 3-Like 1
- LD78beta Chemokine
- Chemokine, LD78beta
- CCL3L1 Chemokine
- Chemokine, CCL3L1
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL3".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL3".
This graph shows the total number of publications written about "Chemokine CCL3" by people in this website by year, and whether "Chemokine CCL3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 3 | 4 |
| 2014 | 0 | 5 | 5 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 2 | 3 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL3" by people in Profiles.
-
SLAMF7 Is a Critical Negative Regulator of IFN-a-Mediated CXCL10 Production in Chronic HIV Infection. J Immunol. 2019 01 01; 202(1):228-238.
-
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy. Leukemia. 2018 04; 32(4):920-930.
-
Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP. Am J Respir Crit Care Med. 2017 08 15; 196(4):494-501.
-
Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype. Crit Care Med. 2016 Nov; 44(11):2010-2017.
-
Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation. Br J Haematol. 2018 02; 180(4):597-600.
-
Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia. J Immunol. 2016 09 15; 197(6):2522-31.
-
CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates. Leuk Lymphoma. 2016; 57(3):563-71.
-
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma. Br J Haematol. 2015 Dec; 171(5):726-35.
-
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL. Leukemia. 2015 Sep; 29(9):1811-22.
-
CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury. EMBO Mol Med. 2014 Oct; 6(10):1231-45.